News & Publications

February 28, 2025

Did you know about Liquid Trapping in your VITROCELL Exposure System?

For sure you have! Everyone needs a universal tool to determine delivered dose directly at the Air-Liquid-Interface (ALI)! But did […]

February 24, 2025

Characterizing the Pulmonary Toxicity and Potential Mutagenicity of Formaldehyde Fumes in a Human Bronchial Epithelial Tissue Model

https://doi.org/10.1002/em.70000 Yuan Le1, Baiping Ren1, Levan Muskhelishvili2, Kelly Davis2, Yiying Wang1, William Gwinn3, Diego Rua4, Robert H. Heflich1, Xuefei Cao11Division […]

February 11, 2025

Evaluation of the toxicity of combustion smokes at the air-liquid interface: a comparison between two lung cell models and two exposure methods

DOI: 10.1007/s00204-025-03964-x A Ashrin 1, E Anna 1, E Peyret 1, G Barbier 1, Maxime Floreani 1, C Pointart 2, […]

February 3, 2025

Application areas and exposure principles for in vitro lung cell research

Discover the application areas and exposure principles for in vitro exposure of cell systems to airborne substances at the air-liquid […]

January 24, 2025

Regulatory authorities recommend VITROCELL Modules for skin exposure to volatile chemicals and liquids

The Science Advisory Committee on Chemicals (SACC) of the US Environmental Protection Agency (EPA) has recently recommended the VITROCELL Skin […]

January 9, 2025

Did you know how to achieve continuous cell exposure of 72 hours at the Air-Liquid Interface (ALI)?

When testing potential hazardous substances at low concentrations, extended exposure durations are essential to realistically assess long-term effects. This is […]

January 2, 2025

Research review and transcriptomic insights into Benzalkonium Chloride inhalation and disease association

https://doi.org/10.1016/j.ecoenv.2024.117610 Jun Woo Kim a, Min Seok Kim a, Ha Ryong Kim ba Center for Respiratory Safety Research, Korea Institute […]

January 2, 2025

Toxicological effects of long-term continuous exposure to ambient air on human bronchial epithelial Calu-3 cells exposed at the air-liquid interface

https://doi.org/10.1016/j.envres.2025.120759 E.J. Zimmermann a b, A. Das a b, A. Huber a b, N. Gawlitta a, E. Kuhn a, C. […]

December 20, 2024

Merry Christmas and Season’s Greetings from VITROCELL!

As the year comes to a close, we would like to express our heartfelt gratitude to all our customers, […]

December 18, 2024

Cigarette Holder Systems for Smoking Machines

In addition to our combustion cigarette holders, we offer a range of device holders specifically designed for electronic cigarettes, including […]

December 17, 2024

Application of the market-ready NAVETTA electrodeposition chamber for controlled in vitro exposure with nano-scaled aerosols

https://doi.org/10.1016/j.csbj.2024.12.008 Magdalena Weiss a, Benjamin Punz a, Jo Van Laer b, An Jacobs b, Sylvie Remy b, Lisa Kleon a, […]

December 16, 2024

Did you know why we, at VITROCELL, offer autoclavable components?

In day-to-day use, decontamination with e.g. ethanol is typically sufficient for components that come into contact with cell cultures and […]

December 3, 2024

Review: Workshop at RIVM

Air-Liquid-Interface (ALI): Advancing Standardization in Continuous Flow Exposure Systems On November 13, 2024, an insightful ALI workshop took place at […]

November 27, 2024

Peer Review of the 2024 Draft Risk Evaluation for 1,1-Dichloroethane and Draft Human Health Hazard Assessment for 1,2-Dichloroethane

Science Advisory Committee on Chemicals MeetingSeptember 17 to 19, 2024 Docket (EPA-HQ-OPPT-2024-0114) Alie Muneer A Set of Scientific Issues Being […]

October 24, 2024

Review: LIST & VITROCELL Workshop 2024

Thank you for a great workshop! A big thank you to all the attendees and organizers of the LIST & […]

October 22, 2024

Press Release: Collaborative Breakthrough in Lung-on-Chip Technology

Collaborative Breakthrough in Lung-on-Chip Technology: AlveoliX, VITROCELL, University of Bern and Helmholtz Institute for Pharmaceutical Research Saarland Drive Advances in […]

October 17, 2024

Quantitative AOP modeling of mucus hypersecretion using 3D cells for comparative risk estimation of heated tobacco product andcombustible cigarette

CORESTA Congress, 13-17 October 2024, Edinburgh, Scotland – UK Shigeaki Ito, Sakuya Ichikawa, Kazuo Erami, Akina Mori, Shugo Muratani, Keigo […]

October 17, 2024

Validation of the Vitrocell® 48 2.0+ 24-well mammalian module for assessing cigarettes and eHTPs: Evaluation of dilution airflow, dose resolution and 3D tissue suitability

CORESTA Congress, 13-17 October 2024, Edinburgh, Scotland – UK A. Seymour, R. Bedford and M. Hollings;Labcorp, Harrogate, UK AbstractThe use […]

October 17, 2024

Multiparameter characterisation of human alveolar macrophage-epithelial co-culture (ImmuLUNG) following exposure to whole smoke

CORESTA Congress, 13-17 October 2024, Edinburgh, Scotland – UK M. Hollings1, E. Rothwell1, R. Bedford1, N. Haydare2, B. Ghiot2, L. […]

October 17, 2024

Advancing Hazard Assessment Studies: Utilizing Inhalation on Chip Platform for Tobacco Product Evaluation

CORESTA Congress, 13-17 October 2024, Edinburgh, Scotland – UK ALEXIS in collaboration with Alveolix and Vitrocell ObjectiveThe goal of this […]

September 27, 2024

VITROCELL featured in Tobacco Journal International (TJI)

We are happy to share the interview with our Manager Director Tobias Krebs which has been published in the August/September […]

September 26, 2024

Did you know why tech leaders in pharmaceutical research rely on us?

VITROCELL Cloud Alpha Systems are exceptional tools for identifying potential drug candidates in preclinical studies. Our Cloud customers carry out […]

September 26, 2024

Did you know how VITROCELL can help in regulatory acceptance of in vitro inhalation toxicology?

In the realm of in vitro inhalation research, precision and reliability are paramount. The recent OECD – OCDE Case Study […]

September 19, 2024

Evaluation of the local tolerance of flagellin aerosol therapy (FLAMOD) on primary human cell-based 3D in vitro nasal, bronchial, small-airway and alveolar models

AIT – Association of Inhalation Toxicology, 17.-19.September 2024, Cleveland, Ohio, USA Mireille Caul-Futy1, Cindia Ferreira1, Christine Caul-Futy2, Rosy Bonfante1, Itziar […]

News & Publications

Did you know about Liquid Trapping in your VITROCELL Exposure System?

Characterizing the Pulmonary Toxicity and Potential Mutagenicity of Formaldehyde Fumes in a Human Bronchial Epithelial Tissue Model

Evaluation of the toxicity of combustion smokes at the air-liquid interface: a comparison between two lung cell models and two exposure methods

Application areas and exposure principles for in vitro lung cell research

Regulatory authorities recommend VITROCELL Modules for skin exposure to volatile chemicals and liquids

Did you know how to achieve continuous cell exposure of 72 hours at the Air-Liquid Interface (ALI)?

Research review and transcriptomic insights into Benzalkonium Chloride inhalation and disease association

Toxicological effects of long-term continuous exposure to ambient air on human bronchial epithelial Calu-3 cells exposed at the air-liquid interface

Merry Christmas and Season’s Greetings from VITROCELL!

Cigarette Holder Systems for Smoking Machines

Application of the market-ready NAVETTA electrodeposition chamber for controlled in vitro exposure with nano-scaled aerosols

Did you know why we, at VITROCELL, offer autoclavable components?

Review: Workshop at RIVM

Peer Review of the 2024 Draft Risk Evaluation for 1,1-Dichloroethane and Draft Human Health Hazard Assessment for 1,2-Dichloroethane

Review: LIST & VITROCELL Workshop 2024

Press Release: Collaborative Breakthrough in Lung-on-Chip Technology

Quantitative AOP modeling of mucus hypersecretion using 3D cells for comparative risk estimation of heated tobacco product andcombustible cigarette

Validation of the Vitrocell® 48 2.0+ 24-well mammalian module for assessing cigarettes and eHTPs: Evaluation of dilution airflow, dose resolution and 3D tissue suitability

Multiparameter characterisation of human alveolar macrophage-epithelial co-culture (ImmuLUNG) following exposure to whole smoke

Advancing Hazard Assessment Studies: Utilizing Inhalation on Chip Platform for Tobacco Product Evaluation

VITROCELL featured in Tobacco Journal International (TJI)

Did you know why tech leaders in pharmaceutical research rely on us?

Did you know how VITROCELL can help in regulatory acceptance of in vitro inhalation toxicology?

Evaluation of the local tolerance of flagellin aerosol therapy (FLAMOD) on primary human cell-based 3D in vitro nasal, bronchial, small-airway and alveolar models

Suchfilter

Categories

Tags